Replies to post #125985 on Innovation Pharmaceuticals Inc (IPIX)

[noretreat]

The secondary endpoints are the hints at efficacy, however, and I will be excited to read about that success.

I think 4 weeks for the primary is optimistic, and i am trying hard to keep things realistic. The mood here alternates between bubbling effervescence and the end of the world, with little in between.

I'm looking for a return to 2 bucks or so as the K release gets closer, and maybe 3 bucks when we have the secondary results. There are other things that could get us to those levels as well. but strong K results have the best chance of actually happening in the relatively near term.

"Cellceutix reports Kevetrin meets all primary and secondary endpoints in Phase 1 study at Dana-Farber"